BOB.1/OBF.1 - A Critical Regulator of B Cell Function
Journal:
Current Immunology Reviews (Discontinued)
Volume:
2
Page:
3-12
Author(s):
Cornelia Brunner and Thomas Wirth
Marine Peptides and Related Compounds in Clinical Trial+
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
6
Page:
33-40
Author(s):
Diwan S. Rawat, Mukesh C. Joshi, Penny Joshi and Himanshu Atheaya
The Role of Growth Factors in the Prevention and Treatment of Chemotherapy-Induced Peripheral Neurotoxicity
Journal:
Current Drug Safety
Volume:
1
Page:
35-42
Author(s):
Guido Cavaletti and Paola Marmiroli
Clinical Pharmacology of Cyclophosphamide and Ifosfamide
Journal:
Current Drug Therapy
Volume:
1
Page:
55-84
Author(s):
Jing Zhang, Quan Tian and Shu-Feng Zhou
Novel Agents Aiming at Specific Molecular Targets Increase Chemosensitivity and Overcome Chemoresistance in Hematopoietic Malignancies
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
111-128
Author(s):
Simone Boehrer, Daniel Nowak, Dieter Hoelzer, Paris S. Mitrou and Kai U. Chow
Signal Transduction Therapy for Cancer - Whither Now?
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
1-12
Author(s):
Shoshana Klein and Alexander Levitzki
Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
25-52
Author(s):
Bharat B. Aggarwal, Gautam Sethi, Asha Nair and Haruyo Ichikawa
Molecular Targeting of Cell Death Signal Transduction Pathways in Cancer
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
113-131
Author(s):
Istvan Petak, Janet A. Houghton and Laszlo Kopper
Patent Annotations
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
1
Page:
135-140
Author(s):
Bentham Science Publishers
An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
273-286
Author(s):
Kohji Takara, Toshiyuki Sakaeda and Katsuhiko Okumura